10-Q: Health in Tech Reports Q2 Loss Amidst Carrier Transition

Sentiment:

Quarterly Report


Health in Tech's Q2 results show a revenue decline and increased expenses, with a new carrier transition impacting operations and a significant convertible financing agreement announced.

Capital raiseThe company entered into a Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd. for up to $20 million in common shares.The SEPA includes pre-paid advances totaling $15 million, to be evidenced by convertible promissory notes.The first tranche of $7 million is expected to be advanced shortly after the filing of this report.The convertible promissory notes will bear interest at 8.75% per annum and are convertible into Class A common stock at $1.5735 per share.
Worse than expectedRevenue decreased by 13.5% year-over-year for the quarter.Cost of revenues increased significantly as a percentage of revenue.Operating expenses, particularly sales and marketing, increased substantially.The company reported a net loss for the quarter, contrasting with a profit in the prior year.Accounts receivable increased significantly, indicating potential collection issues.

Summary

  • Health in Tech reported a net loss of $2.51 million for the three months ended June 30, 2026, a significant downturn from a net income of $630,631 in the same period last year.
  • Total revenues decreased by 13.5% to $8.1 million for the three months ended June 30, 2026, compared to $9.3 million in the prior year period, primarily due to a new stop-loss insurance carrier onboarding.
  • Cost of revenues increased by 19.0% to $4.1 million, and as a percentage of revenue, it rose to 51.3% from 32.3% year-over-year.
  • Sales and marketing expenses nearly doubled to $2.2 million, representing 27.5% of revenue, up from 13.2% in the prior year.
  • General and administrative expenses increased by 12.5% to $4.3 million, largely due to a $0.7 million provision for credit losses on other receivables.
  • Research and development expenses increased by 4.6% to $0.9 million.
  • The company announced a $20 million Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd., which includes $15 million in pre-paid advances via convertible promissory notes.
  • As of June 30, 2026, cash and cash equivalents decreased to $6.5 million from $7.7 million at the end of 2025.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as negative due to a significant decrease in revenue and a substantial increase in operating expenses, leading to a net loss. The company is also undertaking a substantial financing arrangement which indicates potential financial strain.

Positives

  • The company launched new self-funded plan administration services in January 2026, aiming to streamline offerings and improve operational efficiency.
  • The SEPA financing provides potential access to up to $20 million in capital, which can support future operations and growth initiatives.
  • Despite the revenue decline, the company's total stockholders' equity increased to $19.6 million from $17.1 million, largely due to the PIPE financing.
  • The company has a diversified customer base with no single business employer accounting for more than 2.5% of total gross revenues.

Negatives

  • The company reported a net loss of $2.51 million for the quarter, compared to a net profit in the prior year.
  • Total revenues decreased by 13.5% to $8.1 million for the quarter.
  • Cost of revenues increased significantly as a percentage of revenue, rising to 51.3% from 32.3%.
  • Sales and marketing expenses nearly doubled as a percentage of revenue, increasing to 27.5% from 13.2%.
  • General and administrative expenses increased, partly due to a $0.7 million provision for credit losses on other receivables.
  • Cash and cash equivalents decreased by approximately $1.15 million.
  • Accounts receivable increased substantially by $7.79 million, indicating potential collection issues during the carrier transition.

Risks

  • The onboarding of a new stop-loss insurance carrier caused temporary sales delays and revenue recognition timing shifts, impacting current financial performance.
  • A significant increase in accounts receivable suggests potential collection challenges during the carrier transition period.
  • The company's reliance on brokers, TPAs, and other third-party agents for business referrals makes network growth critical and a potential risk if not managed effectively.
  • Failure to accurately perform underwriting procedures could lead to increased costs, higher pricing, and reputational damage.
  • The company's ability to secure future funding, as indicated by the SEPA agreement, suggests a reliance on external capital.
  • The company is subject to risks related to cybersecurity incidents or other network disruptions.
  • The company's ability to stay abreast of and comply with new or modified laws and regulations, particularly concerning data privacy, poses a risk.

Future Outlook

The company expects the transition related to the new carrier to be substantially complete by September 2026, with business volume expected to recover during the third quarter. The SEPA financing provides potential capital for sales and distribution expansion, technology and product development, and operations and working capital.

Management Comments

  • The decrease in revenues was primarily attributable to the onboarding of a new stop-loss insurance carrier, which caused sales delays to later months.
  • The onboarding of the new carrier and certain portfolio transfers between carriers were designed to provide greater options and flexibility to employers.
  • Because we recognize revenue ratably over the contractual term of each policy beginning on its effective date, this represents a timing shift in revenue recognition rather than a reduction in underlying business volume and moving a portion of expected 2026 revenue recognition into 2027.
  • We expect collections to normalize as the carrier transition is completed in the third quarter of 2026.

Industry Context

StockSavvy.ai notes that the healthcare insurance technology sector is highly competitive and subject to regulatory changes. The company's strategy of leveraging technology for underwriting and claims processing is common, but execution and carrier relationships are critical. The reported revenue decline and increased costs are concerning in this environment, especially given the ongoing carrier transition.

Comparison to Industry Standards

  • The company's revenue decline of 13.5% in Q2 is concerning, as many insurtech companies are experiencing growth, though some are facing margin pressures.
  • The increase in cost of revenues as a percentage of revenue (51.3%) is higher than typical for established insurance providers, suggesting potential inefficiencies or higher direct costs associated with their platform model.
  • The significant increase in sales and marketing expenses (27.5% of revenue) is aggressive and typical for growth-stage companies, but the concurrent revenue decline raises questions about the efficiency of this spend.
  • The provision for credit losses on other receivables is a notable expense, indicating potential challenges in collecting on certain assets, which is not ideal for financial stability.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Board of DirectorsSanjay Shrestha2026-08-10Resignation due to other professional and personal commitments.

Legal Proceedings

  • The company is a plaintiff in a civil action against former employees in the U.S. District Court for the Southern District of Iowa, alleging violations of contractual and common law obligations related to restrictive covenants.

Stakeholder Impact

  • Shareholders may experience dilution due to the potential issuance of shares under the SEPA and convertible notes.
  • The financial performance decline and reliance on external financing could impact investor confidence.
  • Customers (employers) may benefit from the new self-funded plan administration services, offering more streamlined options.
  • Brokers and TPAs may see continued platform utility, but the carrier transition could introduce temporary operational adjustments.

Next Steps

  • Complete the transition related to the new stop-loss insurance carrier by September 2026.
  • Seek shareholder approval for the issuance of common shares under the SEPA and for the conversion of promissory notes.
  • File a resale registration statement for shares issuable under the SEPA within 21 days of the effective date.
  • Continue investment in technology development and new functionalities for the next-generation platform.

Key Dates

DateDescription
2026-06-30Quarterly period ended
2026-08-10Sanjay Shrestha resigned from the Board of Directors.
2026-08-12Standby Equity Purchase Agreement (SEPA) entered into with YA II PN, Ltd.
2026-08-13Date of filing of the Form 10-Q.

Recommendation

sell

The company's deteriorating financial performance, marked by declining revenues, increasing costs, and a shift to net losses, coupled with a significant reliance on new financing arrangements, suggests a negative outlook. The operational challenges related to carrier transitions further add to the risk profile, making it prudent for investors to consider selling or avoiding the stock until a clear path to profitability and stable operations is demonstrated.

Keywords

Health Insurance, Stop-Loss Insurance, Self-Funded Benefits, Insurtech, Underwriting, Claims Processing, Healthcare Technology, Financial Report

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.